PER 3.57% 8.7¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-337

  1. 35,748 Posts.
    lightbulb Created with Sketch. 554
    Not really relevant to ANP but anyway .... private companies are always "under the radar".

    Only spun out of Mount Sinai few years ago with VC funding from Sanofi & DDF - fits with Mercks other recent neuro deals over last few years.
    Last edited by Akki: 18/03/21
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.003(3.57%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.4¢ 8.7¢ 8.4¢ $72.99K 855.8K

Buyers (Bids)

No. Vol. Price($)
2 452608 8.4¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 398595 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.